88 related articles for article (PubMed ID: 2835652)
1. Conformational determinants of high affinity delta receptor binding of opioid peptides.
Keys C; Payne P; Amsterdam P; Toll L; Loew G
Mol Pharmacol; 1988 May; 33(5):528-36. PubMed ID: 2835652
[TBL] [Abstract][Full Text] [Related]
2. Conformational studies and receptor binding of delta selective opioid peptides.
Keys C; Amsterdam P; Payne P; Toll L; Loew G
NIDA Res Monogr; 1986; 75():57-60. PubMed ID: 2829004
[TBL] [Abstract][Full Text] [Related]
3. [3H]DSTBULET, a new linear hexapeptide with both an improved selectivity and a high affinity for delta-opioid receptors.
Delay-Goyet P; Seguin C; Daugé V; Calenco G; Morgat JL; Gacel G; Roques BP
NIDA Res Monogr; 1986; 75():197-200. PubMed ID: 2828972
[TBL] [Abstract][Full Text] [Related]
4. Roles of residues 3 and 4 in cyclic tetrapeptide ligand recognition by the kappa-opioid receptor.
Przydzial MJ; Pogozheva ID; Bosse KE; Andrews SM; Tharp TA; Traynor JR; Mosberg HI
J Pept Res; 2005 Mar; 65(3):333-42. PubMed ID: 15787963
[TBL] [Abstract][Full Text] [Related]
5. Proposals for the mu-active conformation of the enkephalin analog Tyr-cyclol(-N gamma-D-A2-bu-Gly-Phe-Leu-).
Maigret B; Fournie-Zaluski MC; Roques B; Premilat S
Mol Pharmacol; 1986 Mar; 29(3):314-20. PubMed ID: 3005838
[TBL] [Abstract][Full Text] [Related]
6. Tetrapeptide derivatives of [D-Pen(2),D-Pen(5)]-enkephalin (DPDPE) lacking an N-terminal tyrosine residue are agonists at the mu-opioid receptor.
McFadyen IJ; Sobczyk-Kojiro K; Schaefer MJ; Ho JC; Omnaas JR; Mosberg HI; Traynor JR
J Pharmacol Exp Ther; 2000 Dec; 295(3):960-6. PubMed ID: 11082429
[TBL] [Abstract][Full Text] [Related]
7. Design of high affinity cyclic pentapeptide ligands for kappa-opioid receptors.
Przydzial MJ; Pogozheva ID; Ho JC; Bosse KE; Sawyer E; Traynor JR; Mosberg HI
J Pept Res; 2005 Nov; 66(5):255-62. PubMed ID: 16218993
[TBL] [Abstract][Full Text] [Related]
8. Conformationally readdressed CCK-B/delta-opioid peptide ligands.
Nikiforovich GV; Kolodziej SA; Nock B; Bernad N; Martinez J; Marshall GR
Biopolymers; 1995 Oct; 36(4):439-52. PubMed ID: 7578939
[TBL] [Abstract][Full Text] [Related]
9. Structural requirements for delta opioid receptor binding.
Mosberg HI; Omnaas JR; Goldstein A
Mol Pharmacol; 1987 Jun; 31(6):599-602. PubMed ID: 3037296
[TBL] [Abstract][Full Text] [Related]
10. Interactions among mu- and delta-opioid receptors, especially putative delta1- and delta2-opioid receptors, promote dopamine release in the nucleus accumbens.
Hirose N; Murakawa K; Takada K; Oi Y; Suzuki T; Nagase H; Cools AR; Koshikawa N
Neuroscience; 2005; 135(1):213-25. PubMed ID: 16111831
[TBL] [Abstract][Full Text] [Related]
11. Effect of aromatic amino acid substitutions in the 3-position of cyclic beta-casomorphin analogues on mu-opioid agonist/delta-opioid antagonist properties.
Schmidt R; Wilkes BC; Chung NN; Lemieux C; Schiller PW
Int J Pept Protein Res; 1996 Nov; 48(5):411-9. PubMed ID: 8956074
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and opioid activity of conformationally constrained dynorphin A analogues. 2. Conformational constraint in the "address" sequence.
Arttamangkul S; Ishmael JE; Murray TF; Grandy DK; DeLander GE; Kieffer BL; Aldrich JV
J Med Chem; 1997 Apr; 40(8):1211-8. PubMed ID: 9111295
[TBL] [Abstract][Full Text] [Related]
13. Characterization of the bioactive form and molecular determinants of recognition of cyclic enkephalin peptides at the delta-opioid receptor.
Chew C; Villar HO; Loew GH
Biopolymers; 1993 Apr; 33(4):647-57. PubMed ID: 8385507
[TBL] [Abstract][Full Text] [Related]
14. Binding affinity and selectivity of opioids at mu, delta and kappa receptors in monkey brain membranes.
Emmerson PJ; Liu MR; Woods JH; Medzihradsky F
J Pharmacol Exp Ther; 1994 Dec; 271(3):1630-7. PubMed ID: 7996478
[TBL] [Abstract][Full Text] [Related]
15. Novel mu-selective Met-enkephalinamide analogs with antagonist activity. Synthesis, receptor binding, analgesic properties and conformational studies.
Judd AK; Lawson JA; Olsen CM; Toll LR; Polgar WE; Uyeno ET; Keys CJ; Loew GH
Int J Pept Protein Res; 1987 Sep; 30(3):299-317. PubMed ID: 2826356
[TBL] [Abstract][Full Text] [Related]
16. Comparison of conformational properties of linear and cyclic delta selective opioid ligands DTLET (Tyr-D X Thr-Gly-Phe-Leu-Thr) and DPLPE (Tyr-c[D X Pen-Gly-Phe-Pen]) by 1H n.m.r. spectroscopy.
Belleney J; Roques BP; Fournie-Zaluski MC
Int J Pept Protein Res; 1987 Sep; 30(3):356-64. PubMed ID: 3692682
[TBL] [Abstract][Full Text] [Related]
17. Probes for narcotic receptor-mediated phenomena. 25. Synthesis and evaluation of N-alkyl-substituted (alpha-piperazinylbenzyl)benzamides as novel, highly selective delta opioid receptor agonists.
Katsura Y; Zhang X; Homma K; Rice KC; Calderon SN; Rothman RB; Yamamura HI; Davis P; Flippen-Anderson JL; Xu H; Becketts K; Foltz EJ; Porreca F
J Med Chem; 1997 Aug; 40(18):2936-47. PubMed ID: 9288176
[TBL] [Abstract][Full Text] [Related]
18. Delta opioid receptor enhancement of mu opioid receptor-induced antinociception in spinal cord.
He L; Lee NM
J Pharmacol Exp Ther; 1998 Jun; 285(3):1181-6. PubMed ID: 9618421
[TBL] [Abstract][Full Text] [Related]
19. Topographical requirements for delta-selective opioid peptides.
Nikiforovich GV; Hruby VJ; Prakash O; Gehrig CA
Biopolymers; 1991 Jul; 31(8):941-55. PubMed ID: 1782355
[TBL] [Abstract][Full Text] [Related]
20. Delta and mu opioid receptors from the brain of a urodele amphibian, the rough-skinned newt Taricha granulosa: cloning, heterologous expression, and pharmacological characterization.
Bradford CS; Walthers EA; Stanley DJ; Baugh MM; Moore FL
Gen Comp Endocrinol; 2006 May; 146(3):275-90. PubMed ID: 16375901
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
